Debra Charlotte McCowan sold $478k of HQY
director at HEALTHEQUITY, INC.. 5,000 shares at an average of $95.56, traded Dec 12, 2024, filed Dec 13, 2024.
Score components
- +15RoleDirector
- +18Trade size$478k at market
- +10Share of holdings soldSold 39% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-029324, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2024 | SOpen-market sale Common Stock | -5,000 | $95.56 | $478k | 7,779 | Dec 13, 2024 |
Related signals
Other insiders at HEALTHEQUITY, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | HEALTHEQUITY, INC. | Robert W Selander director | $640k 5,750 shares | -7% | |
| 44Moderate | HEALTHEQUITY, INC. | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | $279k 2,869 shares | -5% | |
| 75Notable | HEALTHEQUITY, INC. | Stuart B. Parker director | $2.4M 25,000 shares | -57% | |
| 23Weak | HEALTHEQUITY, INC. | Robert W Selander director | $838k 8,250 shares | -11% | |
| 23Weak | HQYsell HEALTHEQUITY, INC. | Frank Corvino other | $100k 1,039 shares | -22% | |
| 6Weak | HEALTHEQUITY, INC. | Robert W Selander director | $685k 8,250 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.